Study of over 1000 females with breast cancer finds that genomic risk and molecular subtype, and not race, drives ...

Led by Dr. Sonya Reid, a Black physician, a new study shows how DNA-based tumor analysis can help close the survival gap for ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...

Victoria Rizk, MD, explores genomic assays to refine adjuvant therapy and capture clinical real-world evidence in breast ...

Advanced genetic testing has shown potential in reducing racial disparities in breast cancer survival rates between Black and ...

In a subgroup of black women enrolled in a US breast cancer registry called BEST, women deemed to have low-risk tumours using the MammaPrint test had a 97.7% recurrence-free rate after 10 years, the ...

Forbes contributors publish independent expert analyses and insights. I cover cancer science, treatments and attitudes. Apr 21, 2016, 12:18pm EDT Apr 22, 2016, 08:43am EDT This article is more than 9 ...

SAN FRANCISCO (KPIX) -- Some good news for breast cancer patients. New guidelines issued Monday afternoon say patients with early stage-disease should all get a new test. This test -- the MammaPrint - ...

Agendia, Inc., a leader in precision oncology for breast cancer, today announced that the updated NCCN Clinical Practice Guidelines in Oncology1 (NCCN Guidelines®) now recognize that MammaPrint® + ...

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, today announces that its next-generation sequencing (NGS)-based MammaPrint® BluePrint® Breast Cancer Recurrence ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — A genomic test can help predict which patients with early-stage breast cancer will derive the most ...